ArticleFrontiers in cellular neuroscience2026
TGFβ signalling maintains Sox4+ astrocyte progenitors and restricts the early differentiation of BLBP+ astrocytes in the mouse dentate gyrus.
Article in Frontiers in cellular neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Astrocytes in the mouse hippocampal dentate gyrus (DG) derive, at least in part, from BLBP+ cells, but the mechanism that controls the onset of their differentiation remains poorly understood. To address this, we first characterised the developmental dynamics of BLBP+ cells using Ki67 and the cyclin-dependent kinase inhibitor p57. Ki67+/BLBP+ proliferative progenitors peaked at P1 and declined by P3-P6, when p57+/BLBP+ early-differentiating astrocytes instead accumulated. This temporal switch prompted us to examine what maintains the proliferative pool and restricts premature differentiation. We identified Sox4, a downstream transcription factor of TGFβ signalling, as a selective marker of the undifferentiated astrocytic lineage in the developing DG. At E15-E17, Sox4 was co-expressed with BLBP and pVimentin in basal radial glia (bRG), and at P1-P6 with BLBP, Sox3 and Ki67 in proliferative glial progenitors including the Olig2+/BLBP+ astrocyte progenitors (ASPs) we recently identified. Our data further suggest that Sox4 marks ASPs but not either NeuroD+ neuronal progenitors or p57+/BLBP+ early-differentiating astrocytes. From P14 onwards, Sox4 expression persisted in a subpopulation of BLBP+ radial glia-like cells (RGLs) at the SGZ and in BLBP+ cells in the molecular layer. Together, these data suggest that Sox4 selectively marks BLBP+ glial progenitors (bRG, RGLs and ASPs) but not their differentiated progeny. Consistent with an autocrine TGFβ1-Sox4 pathway described in glioma-initiating cells, TGFβ1 was co-expressed with BLBP in bRG, RGLs and ASPs. Blockade of TGFβ signalling with SB431542 in DG explants depleted Sox4+ progenitors and, in turn, promoted the accumulation of p57+/BLBP+ astrocytes. Our data thus suggest that TGFβ signalling maintains Sox4+ progenitors and thereby restricts the early differentiation of BLBP+ astrocytes in the mouse DG.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.